Stages of Type 1 Diabetes
Type 1 diabetes is caused by the immune system mistakenly attacking and destroying the insulin-producing cells (called pancreatic β-cells) in the islets of Langerhans. This autoimmune process is mediated primarily by autoreactive T-lymphocytes, supported by B-cells and autoantibodies that act as markers of the ongoing immune attack. The loss of β-cells is progressive and ultimately leads to absolute insulin deficiency.
3 Stages of Type 1 Diabetes Development
Research has shown that type 1 diabetes typically unfolds in three recognisable stages:
- Stage 1: The autoimmune process begins, and two or more islet autoantibodies (commonly against insulin, GAD65, IA-2, or ZnT8) can be detected in the blood. At this point, pancreatic insulin secretion remains sufficient to maintain euglycaemia, so blood glucose levels are normal and there are no clinical symptoms.
- Stage 2: As the immune attack continues, a gradual decline in β-cell mass occurs. This leads to dysglycaemia (abnormal blood glucose levels) detectable on an oral glucose tolerance test or continuous monitoring. However, symptoms are still absent because residual β-cell function partly compensates.
- Stage 3: Once β-cell destruction passes a critical threshold (often when 80–90% of β-cell mass is lost), the body can no longer produce enough insulin. Classic symptoms of diabetes such as polyuria, polydipsia, weight loss, and fatigue appear. At this point, the person becomes fully dependent on exogenous insulin for survival.
The tempo of β-cell loss varies greatly between individuals. In children, β-cell destruction is often rapid, leading to sudden onset of symptoms. In adults, especially in latent autoimmune diabetes in adults (LADA), progression may be slower, with some residual insulin production persisting for years.
Immunopathogenesis
The autoimmune response in type 1 diabetes is complex. CD8+ cytotoxic T cells infiltrate the pancreatic islets (a process called insulitis) and directly kill β-cells. CD4+ helper T cells amplify the immune attack, while autoantibodies mark the presence of disease activity but do not appear to cause β-cell destruction themselves. Inflammatory cytokines (such as interleukin-1β, interferon-γ, and tumour necrosis factor-α) further damage β-cells, impairing insulin secretion even before complete destruction.
Genetic Risk
Type 1 diabetes has a strong polygenic component. The overall heritability is estimated at 40–60%, with the greatest influence coming from the human leukocyte antigen (HLA) class II region on chromosome 6. Specific alleles (such as HLA-DR3, HLA-DR4, and DQ8) greatly increase susceptibility by shaping how the immune system recognises self-antigens. Beyond HLA, more than 60 non-HLA loci contribute to risk, including genes regulating immune tolerance (e.g., PTPN22, CTLA4, and IL2RA).
Despite this strong genetic influence, concordance between identical twins is only about 30–50%, showing that environmental factors are essential in triggering disease onset.
Environmental Triggers
Environmental exposures appear to “activate” autoimmunity in genetically susceptible individuals. Potential triggers include:
- Viral infections: Particularly enteroviruses, which may cause molecular mimicry (viral proteins resembling β-cell antigens) or direct β-cell injury.
- Gut microbiome changes: Altered microbial diversity in early life may disturb immune tolerance.
- Dietary factors: Early introduction of cow’s milk protein, gluten, or low vitamin D levels have been explored, although evidence remains inconclusive.
- Stress or other environmental insults: These may accelerate autoimmune activity, though mechanisms are unclear.
Loss of Insulin and Clinical Manifestations
As β-cell destruction advances, the pancreas can no longer secrete sufficient insulin. Insulin is crucial not only for glucose uptake in muscle and fat tissue but also for suppressing hepatic glucose production. Without it, glucose accumulates in the blood (hyperglycaemia), leading to glycosuria, dehydration, and metabolic dysregulation. In severe cases, unchecked insulin deficiency causes diabetic ketoacidosis (DKA), a life-threatening emergency characterised by ketone body accumulation, metabolic acidosis, and electrolyte imbalance.
In summary, type 1 diabetes results from a complex interplay of genetic susceptibility and environmental triggers, which activate an autoimmune process that progressively destroys pancreatic β-cells. The clinical disease emerges only after a long, often silent, pre-symptomatic phase, highlighting the importance of early detection and potential intervention in high-risk individuals.
Page updated September 2025
